Erratum to hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial.

[This corrects the article DOI: 10.21037/jtd-2020-057.]. 2020 Journal of Thoracic Disease. All rights reserved.

Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial

In the article that appeared on Page 3448-3452, Vol 12, No 6 (June 2020) Issue of the Journal of Thoracic Disease (JTD) (1), there is a numerical error occurred in the following sentence:

“On the basis of standard-of-care (3), patients in treatment group inhaled H2-O2 (66% hydrogen; 33% oxygen) at 6 L/min via nasal cannula by using the Hydrogen/Oxygen Generator (model AMS-H-03, Shanghai Asclepius Meditec Co., Ltd., China) daily until discharge [see Figure E1 in Online Supplement (http://dx.doi.org/10.21037/jtd-2020-057)].”

The number given as “6 L/min” should have been “3 L/min”. The sentence should read:

“On the basis of standard-of-care (3), patients in treatment group inhaled H2-O2 (66% hydrogen; 33% oxygen) at 3 L/min via nasal cannula by using the Hydrogen/Oxygen Generator (model AMS-H-03, Shanghai Asclepius Meditec Co., Ltd., China) daily until discharge [see Figure E1 in Online Supplement (http://dx.doi.org/10.21037/jtd-2020-057)].”

This numerical error does not affect the results or conclusions of the study.

The authors regret the error.